|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brower JV, Clark PA, Lyon W and Kuo JS:
MicroRNAs in cancer: Glioblastoma and glioblastoma cancer stem
cells. Neurochem Int. 77:68–77. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Murphy AM and Rabkin SD: Current status of
gene therapy for brain tumors. Transl Res. 161:339–354. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhang Z, Li X, Xiao Q and Wang Z:
MiR-574-5p mediates the cell cycle and apoptosis in thyroid cancer
cells via Wnt/beta-catenin signaling by repressing the expression
of Quaking proteins. Oncol Lett. 15:5841–5848. 2018.PubMed/NCBI
|
|
6
|
Luo T, Yan Y, He Q, Ma X and Wang W:
miR-328-5p inhibits MDA-MB-231 breast cancer cell proliferation by
targeting RAGE. Oncol Rep. 39:2906–2914. 2018.PubMed/NCBI
|
|
7
|
Li Z, Guo J, Ma Y, Lin Z and Zhang L:
Oncogenic role of MicroRNA-30b-5p in glioblastoma through targeting
proline-rich transmembrane protein 2. Oncol Res. 26:219–230. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Xu R, Zhu X, Chen F, Huang C, Ai K, Wu H,
Zhang L and Zhao X: LncRNA XIST/miR-200c regulates the stemness
properties and tumourigenicity of human bladder cancer stem
cell-like cells. Cancer Cell Int. 18:412018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhu Y, Zhao H, Rao M and Xu S:
MicroRNA-365 inhibits proliferation, migration and invasion of
glioma by targeting PIK3R3. Oncol Rep. 37:2185–2192. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang T, Ma G, Zhang Y, Huo H and Zhao Y:
miR-599 inhibits proliferation and invasion of glioma by targeting
periostin. Biotechnol Lett. 39:1325–1333. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jiang L, Wang C, Lei F, Zhang L, Zhang X,
Liu A, Wu G, Zhu J and Song L: miR-93 promotes cell proliferation
in gliomas through activation of PI3K/Akt signaling pathway.
Oncotarget. 6:8286–8299. 2015.PubMed/NCBI
|
|
12
|
Chen H, Pan H, Qian Y, Zhou W and Liu X:
MiR-25-3p promotes the proliferation of triple negative breast
cancer by targeting BTG2. Mol Cancer. 17:42018. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Casadei L, Calore F, Creighton CJ,
Guescini M, Batte K, Iwenofu OH, Zewdu A, Braggio DA, Bill KL,
Fadda P, et al: Exosome-derived miR-25-3p and miR-92a-3p stimulate
liposarcoma progression. Cancer Res. 77:3846–3856. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zhang J, Gong X, Tian K, Chen D, Sun J,
Wang G and Guo M: miR-25 promotes glioma cell proliferation by
targeting CDKN1C. Biomed Pharmacother. 71:7–14. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Peng G, Yuan X, Yuan J, Liu Q, Dai M, Shen
C, Ma J, Liao Y and Jiang W: miR-25 promotes glioblastoma cell
proliferation and invasion by directly targeting NEFL. Mol Cell
Biochem. 409:103–111. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cao J, Ge MH and Ling ZQ: Fbxw7 tumor
suppressor: A vital regulator contributes to human tumorigenesis.
Medicine (Baltimore). 95:e24962016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhou C, Shen L, Mao L, Wang B, Li Y and Yu
H: miR-92a is upregulated in cervical cancer and promotes cell
proliferation and invasion by targeting FBXW7. Biochem Biophys Res
Commun. 458:63–69. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lin J, Ji A, Qiu G, Feng H, Li J, Li S,
Zou Y, Cui Y, Song C, He H and Lu Y: FBW7 is associated with
prognosis, inhibits malignancies and enhances temozolomide
sensitivity in glioblastoma cells. Cancer Sci. 109:1001–1011. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee EJ, Jo M, Rho SB, Park K, Yoo YN, Park
J, Chae M, Zhang W and Lee JH: Dkk3, downregulated in cervical
cancer, functions as a negative regulator of beta-catenin. Int J
Cancer. 124:287–297. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li Q, Shen K, Zhao Y, Ma C, Liu J and Ma
J: MiR-92b inhibitor promoted glioma cell apoptosis via targeting
DKK3 and blocking the Wnt/beta-catenin signaling pathway. J Transl
Med. 11:3022013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mizobuchi Y, Matsuzaki K, Kuwayama K,
Kitazato K, Mure H, Kageji T and Nagahiro S: REIC/Dkk-3 induces
cell death in human malignant glioma. Neuro Oncol. 10:244–253.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Pisapia DJ: The updated world health
organization glioma classification: Cellular and molecular origins
of adult infiltrating gliomas. Arch Pathol Lab Med. 141:1633–1645.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Malzkorn B, Wolter M, Liesenberg F,
Grzendowski M, Stühler K, Meyer HE and Reifenberger G:
Identification and functional characterization of microRNAs
involved in the malignant progression of gliomas. Brain Pathol.
20:539–550. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xiao F, Li Y, Wan Y and Xue M:
MircroRNA-139 sensitizes ovarian cancer cell to cisplatin-based
chemotherapy through regulation of ATP7A/B. Cancer Chemother
Pharmacol. 81:935–947. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Ruan L, Chen J, Ruan L, Yang T and Wang P:
MicroRNA-186 suppresses lung cancer progression by targeting SIRT6.
Cancer Biomark. 21:415–423. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hagedorn M, Delugin M, Abraldes I, Allain
N, Belaud-Rotureau MA, Turmo M, Prigent C, Loiseau H, Bikfalvi A
and Javerzat S: FBXW7/hCDC4 controls glioma cell proliferation in
vitro and is a prognostic marker for survival in glioblastoma
patients. Cell Div. 2:92007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Cao S, Wang Y, Li J, Lv M, Niu H and Tian
Y: Tumor-suppressive function of long noncoding RNA MALAT1 in
glioma cells by suppressing miR-155 expression and activating FBXW7
function. Am J Cancer Res. 6:2561–2574. 2016.PubMed/NCBI
|
|
29
|
Hua Y, Zhao K, Tao G, Dai C and Su Y:
miR-25 promotes metastasis via targeting FBXW7 in esophageal
squamous cell carcinoma. Oncol Rep. 38:3030–3038. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xiang J, Hang JB, Che JM and Li HC: MiR-25
is up-regulated in non-small cell lung cancer and promotes cell
proliferation and motility by targeting FBXW7. Int J Clin Exp
Pathol. 8:9147–9153. 2015.PubMed/NCBI
|
|
31
|
Gong J, Cui Z, Li L, Ma Q, Wang Q, Gao Y
and Sun H: MicroRNA-25 promotes gastric cancer proliferation,
invasion, and migration by directly targeting F-box and WD-40
domain protein 7, FBXW7. Tumour Biol. 36:7831–7840. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Huo J, Zhang Y, Li R, Wang Y, Wu J and
Zhang D: Upregulated MicroRNA-25 mediates the migration of melanoma
cells by targeting DKK3 through the WNT/beta-Catenin Pathway. Int J
Mol Sci. 17:E11242016. View Article : Google Scholar : PubMed/NCBI
|
